RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034

Name: RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Download Sample Buy Report

RNA Targeting Small Molecules Therapeutics Market 2025 – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings), By Therapeutic Indication (Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications), By Application (Drug Discovery, Oncology Research, Disease Identification), By End User (Hospitals, Research Laboratories, Pharmaceutical and Biotechnology Companies, Other End-Users), And By Region, Opportunities And Strategies – Global Forecast To 2035

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034

Report Price : $4490.00 | Pages : 363 | Published : October 2025 | Delivery Time: Immediately | Format :

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Regional Data

RNA (Ribonucleic Acid) targeting small molecule therapeutics Market Definition

RNA (Ribonucleic Acid) targeting small molecule therapeutics are a class of pharmaceutical compounds designed to specifically interact with RNA molecules within cells, modulating their function and activity to treat various diseases. RNA molecules play critical roles in gene expression, protein synthesis and cellular regulation and dysregulation of RNA function is implicated in numerous diseases, including cancer, genetic disorders, viral infections and neurodegenerative diseases.

The RNA targeting small molecule therapeutics market consists of sales of RNA targeting small molecule therapeutics by entities (organizations, sole traders or partnerships) that are engaged in the research, development and commercialization of therapeutic agents designed to interact with RNA through various mechanisms. These offerings include mRNA translation modulators that affect the process by which messenger RNA (mRNA) is translated into proteins, RNA splicing modifiers that alter the way in which RNA is spliced and various segments are joined together to form mature mRNA, direct RNA targeting molecules that bind directly to RNA to affect its function and other innovative approaches to RNA targeting.

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034 Market Size and growth rate 2025 to 2029: Graph

RNA (Ribonucleic Acid) targeting small molecule therapeutics Market Size

The global RNA targeting small molecules therapeutics market reached a value of nearly $2,775.64 million in 2024, having grown at a compound annual growth rate (CAGR) of 31.74% since 2019. The market is expected to grow from $2,775.64 million in 2024 to $4,130.75 million in 2029 at a rate of 8.28%. The market is then expected to grow at a CAGR of 11.25% from 2029 and reach $7,039.75 million in 2034.

Growth in the historic period resulted from increasing incidence of neurological disorders, growing demand for precision medicine, increased healthcare expenditure and expansion of clinical trials and robust therapeutic pipeline. Factors that negatively affected growth in the historic period were the high cost of drug development and complexity of RNA-based drug discovery.

Going forward, the government initiatives for research and development in healthcare, venture capital and pharma investment in RNA, increasing incidence of genetic disorders and rising prevalence of cancer support will drive growth. Factors that could hinder the growth of the RNA targeting small molecules therapeutics market in the future include instability and degradation of RNA targets, off-target effects and toxicity risks and trade war and tariffs.

RNA (Ribonucleic Acid) Targeting Small Molecule Therapeutics Market Drivers

The key drivers of the RNA (Ribonucleic Acid) targeting small molecule therapeutics market include:

Increasing Incidence Of Genetic Disorders

Increasing incidence of genetic disorders are expected to propel the growth of the RNA targeting small molecule therapeutics market going forward. RNA-targeting therapies offer an innovative approach to addressing the underlying causes of genetic disorders by modulating gene expression or correcting defective RNA mechanisms. With the rising prevalence of genetic conditions, demand for advanced and targeted treatments is increasing. This trend presents significant opportunities for pharmaceutical and biotechnology companies to accelerate research, expand clinical trial pipelines and introduce innovative RNA-based therapies to the market. The increasing incidence of genetic disorders during the forecast period in 2024 is 0.50.

RNA (Ribonucleic Acid) Targeting Small Molecule Therapeutics Market Restraints

The key restraints on the rna (ribonucleic acid) targeting small molecule therapeutics market include:

Off-Target Effects And Toxicity Risks

Off-target effects and toxicity risks are expected to restrain the growth of the RNA targeting small molecule therapeutics market during the forecast period by raising significant safety concerns during drug development and clinical trials. Unintended interactions with non-target RNAs or proteins can lead to adverse side effects, limiting therapeutic applicability. These risks increase the complexity of designing precise and selective molecules, thereby slowing innovation. Additionally, higher toxicity profiles can result in regulatory delays, trial failures and increased development costs. Such challenges reduce investor confidence and hinder large-scale adoption of RNA-targeted therapies. Growth affected by off-target effects and toxicity risks during the forecast period in 2024 is -2.13%.

Rna (Ribonucleic Acid) Targeting Small Molecule Therapeutics Market Trends

Major trends shaping the rna (ribonucleic acid) targeting small molecule therapeutics market include:

AI-Powered Deep Learning Revolutionizes RNA-Targeted Small Molecule Drug Discovery

Companies operating in the RNA targeting small molecule therapeutics market are focusing on using AI-driven deep-learning tool to accelerate drug discovery, optimize RNA-target interactions and identify novel therapeutic candidates with higher precision and efficiency. An AI-driven deep-learning tool is a software application or platform that uses artificial intelligence (AI) techniques, specifically deep learning, to perform tasks, analyze data and generate outputs that normally require human intelligence. For instance, in April 2025, Vanderbilt University, a private research university in Nashville, Tennessee, USA, developed, RNAmigos2, an AI-driven deep-learning tool that accelerates the discovery of RNA-targeting small-molecule drugs by 10,000 times compared to traditional methods. RNAmigos2 uses advanced RNA 3D modeling and synthetic data to rapidly and accurately screen large compound libraries, overcoming prior limitations in RNA drug discovery. This open-source tool aims to transform early-stage RNA drug discovery and enable the development of new therapies for diseases such as cancer and viral infections within a few years.

Strategic Alliance To Develop RNA Splicing Modulators For Challenging Diseases

Major companies operating in the RNA targeting small molecule therapeutics market are focusing on strategic alliance to combine expertise, accelerate drug discovery and expand their therapeutic pipelines. Such collaborations enable faster development of innovative RNA-based treatments and access to new markets. For instance, in December 2024, GSK plc, a British multinational pharmaceutical and biotechnology company, partnered with Rgenta Therapeutics Inc, a private biotechnology company focused on developing oral, small-molecule RNA-targeting medicines, to develop RNA-targeting small molecule splice modulators for disease areas including oncology. This multi-year, multi-target strategic alliance aims to advance the discovery and development of novel RNA-targeted therapies that modulate RNA splicing to address difficult-to-treat diseases. The collaboration leverages Rgenta’s proprietary platform and allows GSK to nominate targets for development, with the goal of accelerating new therapeutic options for patients through innovative RNA-based medicines. Rgenta Therapeutics Inc, a US-based clinical-stage company dedicated to developing life-changing medicines for patients with hard-to-treat diseases.

Opportunities And Recommendations In The RNA targeting small molecule therapeutics market Market

Opportunities – The top opportunities in the RNA targeting small molecules therapeutics market segmented by offering will arise in the RNA (Ribonucleic Acid) splicing modification segment, which will gain $752.88 million of global annual sales by 2029. The top opportunities in the RNA targeting small molecules therapeutics market segmented by therapeutic indication will arise in the neurodegenerative diseases segment, which will gain $734.93 million of global annual sales by 2029. The top opportunities in the RNA targeting small molecules therapeutics market segmented by application will arise in the drug discovery segment, which will gain $682.43 million of global annual sales by 2029. The top opportunities in the RNA targeting small molecules therapeutics market segmented by end user will arise in the pharmaceutical and biotechnology companies segment, which will gain $763.80 million of global annual sales by 2029. The RNA targeting small molecules therapeutics market size will gain the most in the USA at $482.45 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the RNA targeting small molecules therapeutics companies to focus on advancing ai-driven tools for rna-targeted drug discovery, focus on advancing ai-driven tools for rna-targeted drug discovery, focus on ai integration to enhance rna small molecule discovery, focus on mrna translation modulators and other high growth segments, focus on cancer as the fastest growing therapeutic segment, expand in emerging markets, continue to focus on developed markets, focus on strategic alliances to accelerate rna therapeutics development, focus on strategic collaborations to strengthen rna therapeutics development, focus on competitive and value-based pricing strategies, focus on building credibility through scientific and clinical communication, focus on targeted outreach and stakeholder-specific messaging, focus on disease identification as the fastest growing market segment, focus on pharmaceutical and biotechnology companies as the fastest growing segment.

Book your 30 minutes free consultation with our research experts

RNA targeting small molecule therapeutics market Market Segmentation

The RNA targeting small molecule therapeutics market market is segmented by offering, by therapeutic indication, by application and by end user.

By Offering –

The RNA Targeting Small Molecule Therapeutics market is segmented By Offering into:

a) mRNA (Messenger Ribonucleic Acid) Translation Modulators

b) RNA (Ribonucleic Acid) Splicing Modification

c) Direct RNA (Ribonucleic Acid) Targeting

d) Other Offerings

The RNA (Ribonucleic Acid) splicing modification market was the largest segment of the RNA targeting small molecules therapeutics market segmented by offering, accounting for 66.76% or $1,853.14 million of the total in 2024. Going forward, the RNA (Ribonucleic Acid) splicing modification segment is expected to be the fastest growing segment in the RNA targeting small molecules therapeutics market segmented by offering, at a CAGR of 7.06% during 2024-2029.

By Therapeutic Indication –

The RNA Targeting Small Molecule Therapeutics market is segmented by therapeutic indication into:

a) Lung Fibrosis

b) Cancer

c) Neurodegenerative Diseases

d) Autoimmune

e) Inflammatory

f) Other Therapeutic Indications

The neurodegenerative diseases market was the largest segment of the RNA targeting small molecules therapeutics market segmented by therapeutic indication, accounting for 66.76% or $1,853.14 million of the total in 2024. Going forward, the neurodegenerative diseases segment is expected to be the fastest growing segment in the RNA targeting small molecules therapeutics market segmented by therapeutic indication, at a CAGR of 6.91% during 2024-2029.

By Application –

The RNA Targeting Small Molecule Therapeutics market is segmented by application into:

a) Drug Discovery

b) Oncology Research

c) Disease Identification

The drug discovery market was the largest segment of the RNA targeting small molecules therapeutics market segmented by application, accounting for 56.36% or $1,564.49 million of the total in 2024. Going forward, the disease identification segment is expected to be the fastest growing segment in the RNA targeting small molecules therapeutics market segmented by application, at a CAGR of 12.50% during 2024-2029.

By End User –

The RNA Targeting Small Molecule Therapeutics market is segmented by end user into:

a) Hospitals

b) Research Laboratories

c) Pharmaceutical And Biotechnology Companies

d) Other End-Users

The pharmaceutical and biotechnology companies market was the largest segment of the RNA targeting small molecules therapeutics market segmented by end user, accounting for 55.39% or $1,537.38 million of the total in 2024. Going forward, the research laboratories segment is expected to be the fastest growing segment in the RNA targeting small molecules therapeutics market segmented by end user, at a CAGR of 8.57% during 2024-2029.

By Geography - The RNA Targeting Small Molecule Therapeutics market is segmented by geography into:

o Asia Pacific

• China

• India

• Japan

• Australia

• Indonesia

• South Korea

o North America

• USA

• Canada

o South America

• Brazil

o Western Europe

• France

• Germany

• UK

• Italy

• Spain

o Eastern Europe

• Russia

o Middle East

o Africa

North America was the largest region in the RNA targeting small molecules therapeutics market, accounting for 43.99% or $1,221.09 million of the total in 2024. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the RNA targeting small molecules therapeutics market will be Africa and Eastern Europe where growth will be at CAGRs of 11.60% and 10.56% respectively. These will be followed by Middle East and South America where the markets are expected to grow at CAGRs of 10.44% and 10.01% respectively.

RNA Targeting Small Molecules Therapeutics Market Competitive Landscape

Major Competitors are:

F.Hoffmann-La Roche Ltd. (Genentech)

Teva Pharmaceuticals

Cipla Limited

Dr. Reddy’s Laboratories

Zydus Lifesciences (formerly Cadila Healthcare)

Other Competitors Include:

Apotex Inc.

Vernalis Research

Viva Biotech Ltd

Aragen Life Sciences

Skyhawk Therapeutics

Ono Pharmaceutical Co., Ltd.

Takeda Pharmaceutical Company

Reborna Biosciences, Inc.

Kyowa Kirin Co., Ltd.

Servier Laboratories

Sanofi S.A.

Abivax SA

Novartis AG

Bayer AG

Rgenta Therapeutics

Anima Biotech

Merck KGaA

Novo Nordisk

AstraZeneca

Arrakis Therapeutics

Expansion Therapeutics

Accent Therapeutics

Serna Bio (previously Ladder Therapeutics)

GSK plc

Rgenta Therapeutics Inc

Remix Therapeutics

NextRNA Therapeutics, Inc.

AION Labs

Author: Abdul Wasay

RNA Targeting Small Molecules Therapeutics Market Size

The global RNA targeting small molecule therapeutics market reached a value of nearly $4,776.0 million in 2023, having grown at a compound annual growth rate (CAGR) of 28.8% since 2018. The market is expected to grow from $4,776.0 million in 2023 to $17,327.6 million in 2028 at a rate of 29.4%. The market is then expected to grow at a CAGR of 28.3% from 2028 and reach $60,229.5 million in 2033.

Growth in the historic period resulted from the increasing incidence of neurological disorders, growing interest in personalized medicine and government initiatives for research and development in healthcare. Factors that negatively affected growth in the historic period were complexity of RNA-based drug discovery.

Going forward, increasing government funding for RNA research, rising prevalence of cancer and increasing incidence of genetic disorders will drive the growth. Factor that could hinder the growth of the RNA targeting small molecule therapeutics market in the future include high cost of drug development.

RNA Targeting Small Molecules Therapeutics Market Drivers

The key drivers of the RNA targeting small molecules therapeutics market include:

Increasing Government Funding For RNA Research

The increasing government funding for RNA research is expected to contribute to the growth of the RNA targeting small molecule therapeutics market during the forecast period. Government funding for RNA research refers to the financial support provided by governmental agencies to facilitate scientific investigations into the roles, functions and potential applications of RNA molecules in various fields such as medicine and fundamental biological research. Increasing government funding for RNA research is driven by recognition of its potential to revolutionize healthcare, biotechnology and understanding fundamental biological processes. Government funding for RNA research facilitates RNA targeting small molecule therapeutics by supporting basic research, technology development and collaborative initiatives, thereby accelerating the identification and optimization of small molecules for therapeutic intervention. For instance, in February 2024, according to the U.S. National Science Foundation, a US-based independent federal agency, National Science Foundation (NSF) and National Human Genome Research Institute (NHGRI) awarded $12.7 million to nine research teams for exploring RNA's potential in diverse biotech applications, from crop disease prevention to cancer therapies. Therefore, the increasing government funding for RNA research will drive the RNA targeting small molecule therapeutics market.

RNA Targeting Small Molecules Therapeutics Market Restraints

The key restraints on the RNA targeting small molecules therapeutics market include:

High Cost Of Drug Development

The high cost of drug development is expected to hamper the growth of the RNA targeting small molecule therapeutics market in the forecast period. Drug development is the process of discovering, designing and bringing pharmaceutical products to market to address medical needs. The high cost of drug development can hinder RNA targeting small molecule therapeutics by limiting research funding and industry investment, thereby impeding progress in identifying effective therapeutics. For instance, in February 2023, the cost of FDA drug approvals for a new drug entering the market in 2022 has risen to $2 million. Therefore, the high cost of drug development can hamper the RNA targeting small molecule therapeutics market going forward.

RNA Targeting Small Molecules Therapeutics Market Trends

Major trends shaping the RNA targeting small molecules therapeutics market include:

Strategic Collaboration Fueling RNA Targeting Small Molecules Therapeutics

Companies operating in the RNA targeting small molecule therapeutics market are focusing on strategic collaborations to enhance their research and development efforts. Strategic collaboration enhances RNA targeting small molecule therapeutics by pooling expertise and resources for accelerated innovation. For instance, in January 2024, Remix Therapeutics, a US-based clinical-stage biotechnology company specializing in small molecule therapies targeting RNA processing, collaborated with F. Hoffmann-La Roche AG, a Switzerland-based biopharmaceutical company. The strategic collaboration between Remix Therapeutics and Roche signifies a significant advancement in the field of RNA modulation for drug discovery. This partnership, focusing on discovering and developing small molecule therapeutics with the REMaster drug discovery platform, marks a notable progression in RNA modulation for drug discovery, combining Remix Therapeutics' platform with Roche's global expertise. It holds the potential for innovative solutions to address medical gaps and transform therapeutic strategies.

Key Players Embrace Startup Solutions In RNA Targeting Small Molecules Therapeutics

Companies in the RNA targeting small molecule therapeutics market are focusing on innovative startup solutions to optimize drug design and enhance RNA-targeted therapeutic development. These solutions facilitate target identification, molecular design and predictive modeling for efficacy and safety to contribute to the health and well-being of all people worldwide. For instance, in February 2024, AION Labs, an Israel-based venture hub for drug discovery and BioMed X, a Germany-based research institute, launched a global call for applications to identify computational biologists, biomedical scientists and inventors to form a new startup at AION Labs. It focuses on the development of an artificial intelligence (AI) and machine learning (ML) computational platform to identify functional regions in RNA that can be targeted with small molecules. RNA has traditionally been deemed unsuitable for small-molecule binding.

Opportunities And Recommendations In The RNA Targeting Small Molecules Therapeutics Market

Opportunities – The top opportunities in the RNA targeting small molecule therapeutics market segmented by type will arise in the ASO segment, which will gain $8,384.0 million of global annual sales by 2028. The top opportunities in the RNA targeting small molecule therapeutics market segmented by therapeutic indication will arise in the musculoskeletal disorder segment, which will gain $8,409.9 million of global annual sales by 2028. The top opportunities in the RNA targeting small molecule therapeutics market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $7,089.1 million of global annual sales by 2028. The RNA targeting small molecule therapeutics market size will gain the most in the USA at $4,632.5 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends RNA targeting small molecules therapeutics companies to focus on ai integration for enhanced drug discovery, focus on advancing RNA degrader therapeutics, focus on MRNA small molecule drug discovery, focus on SIRNA market segment, focus on musculoskeletal disorder and cardiovascular disease segments, expand in emerging markets, continue to focus on developed markets, focus on strategic collaborations for accelerated innovation, provide competitively priced offerings, continue to use B2B promotions, focus on pharmaceutical and biotechnology companies and research laboratories and focus on cancer patients.

RNA Targeting Small Molecules Therapeutics Market Segmentation

The RNA targeting small molecules therapeutics market is segmented by product, by therapeutic indication and by end-user.

By Product –
The RNA targeting small molecules therapeutics market is segmented by product into:

a) Antisense Oligonucleotides (ASOs)
b) Small Interfering RNA (siRNA)

The antisense oligonucleotides (ASOs) market was the largest segment of the RNA targeting small molecule therapeutics market segmented by type, accounting for 68.8% or $3,286.0 million of the total in 2023. Going forward, the siRNA is expected to be the fastest growing segment in the RNA targeting small molecule therapeutics market segmented by type, at a CAGR of 30.6% during 2023-2028.

By Therapeutic Indication –
The RNA targeting small molecules therapeutics market is segmented by therapeutic indication into:

a) Musculoskeletal Disorder
b) neurodegenerative diseases
c) cardiovascular disease
d) Genito-Urinary
e) Therapeutic Indications

The musculoskeletal disorder market was the largest segment of the RNA targeting small molecule therapeutics market segmented by therapeutic indication, accounting for 61.7% or $2,947.8 million of the total in 2023. Going forward, the cardiovascular disease segment is expected to be the fastest growing segment in the RNA targeting small molecule therapeutics market segmented by therapeutic indication, at a CAGR of 32.6% during 2023-2028.

By End Users –
The RNA targeting small molecules therapeutics market is segmented by end users into:

a) Hospitals
b) Research Laboratories
c) Pharmaceutical and Biotechnology Companies
d) Other End-Users

The pharmaceutical and biotechnology companies market was the largest segment of the RNA targeting small molecule therapeutics market segmented by end-user, accounting for 55.1% or $2,630.3 million of the total in 2023. Going forward, the research laboratories segment is expected to be the fastest growing segment in the RNA targeting small molecule therapeutics market segmented by end-user, at a CAGR of 30.3% during 2023-2028.

By Geography - The RNA targeting small molecules therapeutics market is segmented by geography into:

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA
• Canada

• Brazil

• France
• Germany
• UK
• Italy
• Spain

• Russia

North America was the largest region in the RNA targeting small molecule therapeutics market, accounting for 52.8% or $2,522.7 million of the total in 2023. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the RNA targeting small molecule therapeutics market will be South America and Eastern Europe where growth will be at CAGRs of 35.0% and 31.6% respectively. These will be followed by Asia Pacific and Western Europe where the markets are expected to grow at CAGRs of 30.6% and 28.9% respectively.

RNA Targeting Small Molecules Therapeutics Market Competitive Landscape

Major Competitors are:

Ionis Pharmaceuticals

Alnylam Pharmaceuticals

Sarepta Therapeutics

Jazz Pharmaceuticals

Novartis

Other Competitors Include:

NS Pharma

Arrakis Therapeutics

PTC Therapeutics

Anima Biotech Inc.

Ribometrix.

Daiichi Sankyo

Veritas In Silico Inc

RaQualia Pharma

Takeda Pharmaceutical Company Limited

HitGen Inc.

Hutchison China MediTech Limited

Zai Lab Ltd

Innovent Biologics

JW Therapeutics

Otsuka Pharmaceutical Co., Ltd

BioMed X GmbH

Depixus SAS

Bayer AG

Evotec SE

Storm Therapeutics

MiNA Therapeutics

Artios Pharma

Accent Therapeutics

Selvita S.A.

OncoArendi Therapeutics S.A.

Mabion S.A.

Biomed Lublin S.A.

Celon Pharma S.A.

Expansion Therapeutics

Sequence Bio

Serna Bio (previously Ladder Therapeutics).

EMS Pharma

Aspen Pharmacare

Chiesi Farmacêutica

Biolab Pharma

Eurofarma Laboratórios

Igenomix

NewBridge Pharmaceutical

Seegene

Julphar

Aspen Pharmacare Holdings Ltd

Pharco Pharmaceuticals Inc.

Egyptian International Pharmaceutical Industries Company

1 Executive Summary

1.1 RNA Targeting Small Molecules Therapeutics – Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition

6.2 Summary

6.3 RNA Targeting Small Molecules Therapeutics Market Definition And Segmentations

6.4 Market Segmentation By Offering

6.4.1 mRNA (Messenger Ribonucleic Acid) Translation Modulators

6.4.2 RNA (Ribonucleic Acid) Splicing Modification

6.4.3 Direct RNA (Ribonucleic Acid) Targeting

6.4.4 Other Offerings

6.5 Market Segmentation By Therapeutic Indication

6.5.1 Lung Fibrosis

6.5.2 Cancer

6.5.3 Neurodegenerative Diseases

6.5.4 Autoimmune

6.5.5 Inflammatory

6.5.6 Other Therapeutic Indications

6.6 Market Segmentation By Application

6.6.1 Drug Discovery

6.6.2 Oncology Research

6.6.3 Disease Identification

6.7 Market Segmentation By End User

6.7.1 Hospitals

6.7.2 Research Laboratories

6.7.3 Pharmaceutical And Biotechnology Companies

6.7.4 Other End-Users

7 Major Market Trends

7.1 AI-Powered Deep Learning Revolutionizes RNA-Targeted Small Molecule Drug Discovery

7.2 Strategic Alliance To Develop RNA Splicing Modulators For Challenging Diseases

7.3 Strategic Collaboration And Partnership Fueling RNA Targeting Small Molecules Therapeutics

7.4 Focus on Startup-Driven AI Solutions for RNA-Targeted Therapeutics

7.5 Use Of Artificial Intelligence (AI) To Enhance Efficiency Of RNA Targeting Small Molecules

8 Global RNA Targeting Small Molecules Therapeutics Growth Analysis And Strategic Analysis Framework

8.1 Global RNA Targeting Small Molecules Therapeutics PESTEL Analysis

8.1.1 Political

8.1.2 Economic

8.1.3 Social

8.1.4 Technological

8.1.5 Environmental

8.1.6 Legal

8.2 Analysis Of End User (B2B)

8.2.1 Hospitals

8.2.2 Research Laboratories

8.2.3 Pharmaceutical And Biotechnology Companies

8.2.4 Other End-Users

8.3 Global RNA Targeting Small Molecules Therapeutics Market Growth Rate Analysis

8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)

8.4.1 Market Drivers 2019 – 2024

8.4.2 Market Restraints 2019– 2024

8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)

8.6 Forecast Growth Contributors/Factors

8.6.1 Quantitative Growth Contributors

8.6.2 Drivers

8.6.3 Restraints

8.7 Global RNA Targeting Small Molecules Therapeutics Total Addressable Market (TAM)

9 Global RNA Targeting Small Molecules Therapeutics Market Segmentation

9.1 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.2 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.3 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.4 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.5 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of mRNA (Messenger Ribonucleic Acid) Translation Modulators, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.6 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of RNA (Ribonucleic Acid) Splicing Modification, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.7 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Direct RNA (Ribonucleic Acid) Targeting, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.8 Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Other Offerings, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

10 RNA Targeting Small Molecules Therapeutics Market, Regional and Country Analysis

10.1 Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

10.2 Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary

11.2 Market Overview

11.2.1 Region Information

11.2.2 Market Information

11.2.3 Background Information

11.2.4 Government Initiatives

11.2.5 Regulations

11.2.6 Regulatory Bodies

11.2.7 Major Associations

11.2.8 Taxes Levied

11.2.9 Corporate Tax Structure

11.2.10 Investments

11.2.11 Major Companies

11.3 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.4 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.5 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.6 Asia-Pacific RNA Targeting Small Molecules Therapeutics Market: Country Analysis

11.7 China Market

11.8 Summary

11.9 Market Overview

11.9.1 Country Information

11.9.2 Market Information

11.9.3 Background Information

11.9.4 Government Initiatives

11.9.5 Regulations

11.9.6 Regulatory Bodies

11.9.7 Major Associations

11.9.8 Taxes Levied

11.9.9 Corporate Tax Structure

11.9.10 Investments

11.9.11 Major Companies

11.10 China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.11 China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.12 China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.13 India Market

11.14 India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.15 India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.16 India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.17 Japan Market

11.18 Summary

11.19 Market Overview

11.19.1 Country Information

11.19.2 Market Information

11.19.3 Background Information

11.19.4 Government Initiatives

11.19.5 Regulations

11.19.6 Regulatory Bodies

11.19.7 Major Associations

11.19.8 Taxes Levied

11.19.9 Corporate Tax Structure

11.19.10 Investments

11.19.11 Major Companies

11.20 Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.21 Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.22 Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.23 South Korea Market

11.24 Summary

11.25 Market Overview

11.25.1 Country Information

11.25.2 Market Information

11.25.3 Background Information

11.25.4 Government Initiatives

11.25.5 Regulations

11.25.6 Regulatory Bodies

11.25.7 Major Associations

11.25.8 Taxes Levied

11.25.9 Corporate Tax Structure

11.25.10 Major Companies

11.26 South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.27 South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.28 South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.29 Australia Market

11.30 Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.31 Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.32 Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.33 Indonesia Market

11.34 Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.35 Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.36 Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary

12.2 Market Overview

12.2.1 Region Information

12.2.2 Market Information

12.2.3 Background Information

12.2.4 Government Initiatives

12.2.5 Regulations

12.2.6 Regulatory Bodies

12.2.7 Major Associations

12.2.8 Taxes Levied

12.2.9 Corporate Tax Structure

12.2.10 Investments

12.2.11 Major Companies

12.3 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.4 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.5 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.6 UK Market

12.7 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.8 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.9 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.10 Germany Market

12.11 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.12 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.13 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.14 France Market

12.15 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.16 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.17 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.18 Italy Market

12.19 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.20 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.21 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.22 Spain Market

12.23 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.24 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.25 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary

13.2 Market Overview

13.2.1 Region Information

13.2.2 Market Information

13.2.3 Background Information

13.2.4 Government Initiatives

13.2.5 Regulations

13.2.6 Regulatory Bodies

13.2.7 Major Associations

13.2.8 Taxes Levied

13.2.9 Corporate Tax Structure

13.2.10 Major companies

13.3 Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.4 Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.5 Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.6 Russia Market

13.7 Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.8 Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.9 Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary

14.2 Market Overview

14.2.1 Region Information

14.2.2 Market Information

14.2.3 Background Information

14.2.4 Government Initiatives

14.2.5 Regulations

14.2.6 Regulatory Bodies

14.2.7 Major Associations

14.2.8 Taxes Levied

14.2.9 Corporate Tax Structure

14.2.10 Investments

14.2.11 Major Companies

14.3 North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.4 North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.5 North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.6 North America RNA Targeting Small Molecules Therapeutics Market: Country Analysis

14.7 USA Market

14.8 Summary

14.9 Market Overview

14.9.1 Country Information

14.9.2 Market Information

14.9.3 Background Information

14.9.4 Government Initiatives

14.9.5 Regulations

14.9.6 Regulatory Bodies

14.9.7 Major Associations

14.9.8 Taxes Levied

14.9.9 Corporate Tax Structure

14.9.10 Investments

14.9.11 Major Companies

14.10 USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.11 Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.12 USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.13 USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.14 Canada Market

14.15 Summary

14.16 Market Overview

14.16.1 Country Information

14.16.2 Market Information

14.16.3 Background Information

14.16.4 Government Initiatives

14.16.5 Regulations

14.16.6 Regulatory Bodies

14.16.7 Major Associations

14.16.8 Taxes Levied

14.16.9 Corporate Tax Structure

14.16.10 Investments

14.16.11 Major Companies

14.17 Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.18 Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.19 Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary

15.2 Market Overview

15.2.1 Region Information

15.2.2 Market Information

15.2.3 Background Information

15.2.4 Government Initiatives

15.2.5 Regulations

15.2.6 Regulatory Bodies

15.2.7 Major Associations

15.2.8 Taxes Levied

15.2.9 Corporate Tax Structure

15.2.10 Major Companies

15.3 South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.4 South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.5 South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.6 Brazil Market

15.7 Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.8 Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.9 Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary

16.2 Market Overview

16.2.1 Region Information

16.2.2 Market Information

16.2.3 Background Information

16.2.4 Government Initiatives

16.2.5 Regulations

16.2.6 Regulatory Bodies

16.2.7 Major Associations

16.2.8 Taxes Levied

16.2.9 Corporate Tax Structure

16.2.10 Investments

16.2.11 Major Companies

16.3 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

16.4 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

16.5 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary

17.2 Market Overview

17.2.1 Region Information

17.2.2 Market Information

17.2.3 Background Information

17.2.4 Government Initiatives

17.2.5 Regulations

17.2.6 Regulatory Bodies

17.2.7 Major Associations

17.2.8 Taxes Levied

17.2.9 Corporate Tax Structure

17.2.10 Major Companies

17.3 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

17.4 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

17.5 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles

18.2 F.Hoffmann-La Roche Ltd. (Genentech)

18.2.1 Company Overview

18.2.2 Products And Services

18.2.3 Business Strategy

18.2.4 Financial Overview

18.3 Teva Pharmaceuticals

18.3.1 Company Overview

18.3.2 Products And Services

18.3.3 Financial Overview

18.4 Cipla Limited

18.4.1 Company Overview

18.4.2 Products And Services

18.4.3 Financial Overview

18.5 Dr. Reddy’s Laboratories Ltd

18.5.1 Company Overview

18.5.2 Products And Services

18.5.3 Financial Overview

18.6 Zydus Lifesciences (formerly Cadila Healthcare)

18.6.1 Company Overview

18.6.2 Products and Services

18.6.3 Financial Overview

19 Other Major And Innovative Companies

19.1 Apotex Inc.

19.1.1 Company Overview

19.1.2 Products and Services

19.2 Skyhawk Therapeutics

19.2.1 Company Overview

19.2.2 Products and Services

19.3 STORM Therapeutics

19.3.1 Company Overview

19.3.2 Products and Services

19.4 Arrakis Therapeutics Inc.

19.4.1 Company Overview

19.4.2 Products and Services

19.5 Anima Biotech Inc.

19.5.1 Company Overview

19.5.2 Products and Services

19.6 Ribometrix Inc.

19.6.1 Company Overview

19.6.2 Products and Services

19.7 Accent Therapeutics Inc.

19.7.1 Company Overview

19.7.2 Products and Services

19.8 Promega Corporation

19.8.1 Company Overview

19.8.2 Products and Services

19.9 Bayer AG

19.9.1 Company Overview

19.9.2 Products and Services

19.10 Arrowhead Pharmaceuticals Inc.

19.10.1 Company Overview

19.10.2 Products and Services

19.11 Ionis Pharmaceuticals Inc.

19.11.1 Company Overview

19.11.2 Products and Services

19.12 Alnylam Pharmaceuticals

19.12.1 Company Overview

19.12.2 Products and Services

19.13 Abivax SA

19.13.1 Company Overview

19.13.2 Products and Services

19.14 Remix Therapeutics

19.14.1 Company Overview

19.14.2 Products and Services

19.15 858 Therapeutics Inc.

19.15.1 Company Overview

19.15.2 Products and Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Novartis Acquired Regulus Therapeutics Inc.

23 Recent Developments In The RNA Targeting Small Molecule Therapeutics Market

23.1 FDA Approves First Routine Prophylactic Therapy To Reduce Bleeding In Hemophilia Patients

24 Opportunities And Strategies

24.1 Global RNA Targeting Small Molecules Therapeutics Market In 2029 – Countries Offering Most New Opportunities

24.2 Global RNA Targeting Small Molecules Therapeutics Market In 2029 – Segments Offering Most New Opportunities

24.3 Global RNA Targeting Small Molecules Therapeutics Market In 2029 – Growth Strategies

24.3.1 Market Trend Based Strategies

24.3.2 Competitor Strategies

25 RNA Targeting Small Molecules Therapeutics Market, Conclusions And Recommendations

25.1 Conclusions

25.2 Recommendations

25.2.1 Product

25.2.2 Place

25.2.3 Price

25.2.4 Promotion

25.2.5 People

26 Appendix

26.1 Geographies Covered

26.2 Market Data Sources

26.3 Research Methodology

26.4 Currencies

26.5 The Business Research Company

26.6 Copyright and Disclaimer

List Of Tables

Table 1: Global RNA Targeting Small Molecules Therapeutics Market, Historic, 2019 – 2024, $ Million

Table 2: Global RNA Targeting Small Molecules Therapeutics Market, Forecast, 2024 – 2029, 2034F, $ Million

Table 3: Global RNA Targeting Small Molecules Therapeutics Market TAM, 2024 And 2034, $ Million

Table 4: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 5: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 6: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 7: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 8: Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of mRNA (Messenger Ribonucleic Acid) Translation Modulators, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 9: Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of RNA (Ribonucleic Acid) Splicing Modification, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 10: Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Direct RNA (Ribonucleic Acid) Targeting, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 11: Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Other Offerings, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 12: Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 13: Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 14: Asia-Pacific GDP Per Capita, By Country, 2019-2024, $

Table 15: Asia-Pacific Population, By Country, 2019-2029, Millions

Table 16: Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 17: Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 18: Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 19: China GDP Per Capita, 2019-2024, $

Table 20: China Population, 2019-2029, Millions

Table 21: China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 22: China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 23: China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 24: India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 25: India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 26: India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 27: Japan GDP Per Capita, 2018-2023, $

Table 28: Japan Population, By Country, 2019-2029, Millions

Table 29: Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 30: Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 31: Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 32: South Korea GDP Per Capita, 2019-2024, $

Table 33: South Korea Population, 2019-2029, Millions

Table 34: South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 35: South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 36: South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 37: Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 38: Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 39: Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 40: Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 41: Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 42: Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 43: Western Europe GDP Per Capita, By Country, 2019-2024, $

Table 44: Western Europe Population, By Country, 2019-2029, Millions

Table 45: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 46: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 47: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 48: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 49: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 50: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 51: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 52: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 53: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 54: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 55: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 56: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 57: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 58: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 59: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 60: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 61: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 62: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 63: Eastern Europe GDP Per Capita, By Country, 2019-2024, $

Table 64: Eastern Europe Population, By Country, 2019-2029, Millions

Table 65: Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 66: Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 67: Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 68: Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 69: Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 70: Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 71: North America GDP Per Capita, By Country, 2019-2024, $

Table 72: North America Population, By Country, 2019-2029, Millions

Table 73: North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 74: North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 75: North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 76: USA GDP Per Capita, 2019-2024, $

Table 77: USA Population, 2019-2029, Millions

Table 78: USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 79: USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 80: USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 81: Canada GDP Per Capita, 2019-2024, $

Table 82: Canada Population, By Country, 2019-2029, Millions

Table 83: Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 84: Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 85: Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 86: South America GDP Per Capita, By Country, 2019-2024, $

Table 87: South America Population, By Country, 2019-2029, Millions

Table 88: South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 89: South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 90: South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 91: Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 92: Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 93: Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 94: Middle East GDP Per Capita, By Country, 2019-2024, $

Table 95: Middle East Population, By Country, 2019-2029, Millions

Table 96: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 97: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 98: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 99: Africa GDP Per Capita, By Country, 2019-2024, $

Table 100: Africa Population, By Country, 2019-2029, Millions

Table 101: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 102: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 103: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 104: Global RNA Targeting Small Molecule Therapeutics Market, Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 105: F. Hoffmann-La Roche Ltd – Financial Overview, 2020 – 2024, $Billion

Table 106: Teva Pharmaceuticals – Financial Overview, 2020 – 2024, $Billion

Table 107: Cipla Limited – Financial Overview, 2020 – 2024, $Billion

Table 108: Dr. Reddy’s Laboratories Ltd – Financial Overview, 2020 – 2024, $Billion

Table 109: Zydus Lifesciences – Financial Overview, 2020 – 2024, $Billion

Table 110: RNA Targeting Small Molecule Therapeutics Market, Competitive Benchmarking (In USD Millions)

Table 111: RNA Targeting Small Molecule Therapeutics Market, Competitive Dashboard

Table 112: Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), 2024 – 2029, By Country

Table 113: Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By Offering, 2024 – 2029

Table 114: Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By Therapeutic Indication, 2024 – 2029

Table 115: Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By Application, 2024 – 2029

Table 116: Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By End User, 2024 – 2029

Table 117: RNA Targeting Small Molecules Therapeutics Market Data Sources

List Of Figures

Figure 1: Global RNA Targeting Small Molecules Therapeutics Market Segmentation By Offering

Figure 2: Global RNA Targeting Small Molecules Therapeutics Market Segmentation By Therapeutic Indication

Figure 3: Global RNA Targeting Small Molecules Therapeutics Market Segmentation By Application

Figure 4: Global RNA Targeting Small Molecules Therapeutics Market Segmentation By End User

Figure 5: Global RNA Targeting Small Molecules Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 6: Global RNA Targeting Small Molecules Therapeutics Market, Historic, 2019 – 2024, $ Million

Figure 7: Global RNA Targeting Small Molecules Therapeutics Market, Forecast, 2024 – 2029, 2034F, $ Million

Figure 8: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 9: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 10: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 11: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 12: Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of mRNA (Messenger Ribonucleic Acid) Translation Modulators, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 13: Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of RNA (Ribonucleic Acid) Splicing Modification, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 14: Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Direct RNA (Ribonucleic Acid) Targeting, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 15: Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Other Offerings, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 16: Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 17: Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 18: Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 19: Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 20: Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 21: China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 22: China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 23: China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 24: India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 25: India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 26: India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 27: Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 28: Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 29: Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 30: South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 31: South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 32: South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 33: Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 34: Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 35: Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 36: Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 37: Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 38: Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 39: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 40: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 41: Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 42: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 43: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 44: UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 45: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 46: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 47: Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 48: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 49: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 50: France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 51: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 52: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 53: Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 54: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 55: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 56: Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 57: Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 58: Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 59: Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 60: Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 61: Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 62: Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 63: North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 64: North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 65: North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 66: USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 67: USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 68: USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 69: Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 70: Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 71: Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 72: South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 73: South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 74: South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 75: Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 76: Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 77: Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 78: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 79: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 80: Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 81: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 82: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 83: Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 84: Global RNA Targeting Small Molecule Therapeutics, Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 85: F. Hoffmann-La Roche Ltd – Financial Overview, 2020 – 2024, $ Billion

Figure 86: Teva Pharmaceuticals – Financial Overview, 2020 – 2024, $ Billion

Figure 87: Cipla Limited – Financial Overview, 2020 – 2024, $ Billion

Figure 88: Dr. Reddy’s Laboratories Ltd – Financial Overview, 2020 – 2024, $ Billion

Figure 89: Zydus Lifesciences – Financial Overview, 2020 – 2024, $ Billion

Figure 90: Geographic Regions Covered